1. Grever MR, Chabner BA (1997) Cancer drug development. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, PA, p 385
2. Jain RK (1996) Delivery of molecular medicine to solid tumors. Science 271:1079
3. Zamboni WC, Houghton PJ, Hulstein JL, Kirstein M, Walsh J, Cheshire PJ, Hanna SK, Danks MK, Stewart CF (1999) Relationship between tumor extracellular fluid exposure to topotecan and response in human neuroblastoma xenografts and cell lines. Cancer Chemother Pharmacol 43:269–276
4. Balch CM, Reintgen DS, Kirkwood JM et al (1997) Cutaneous melanoma. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, PA, p 1947
5. Muller M, Mader RM, Steiner B, Steger GG, Jansen B, Gnant M, Helbich T, Jakesz R, Eichler HG, Blochl-Daum B (1997) 5-Fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. Cancer Res 57:2598